Start with your question. Search first, choose the closest subject and keep personal details private. Posting guidelines
Notifications
Clear all
Topic starter
29/10/2019 2:51 pm
Bloodwork question about modafinil. Baseline, three years in, and the numbers moved in a direction I did not expect.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
How do you separate the compound effect from the routine around it?
